One of the most significant advantages of partnering with Moorfields’ is our access to an extensive and diverse patient base. Moorfields’, with over 750,000 patient visits each year, serves a broad spectrum of individuals across various age groups, ethnicities, and socio-economic backgrounds. This vast and varied patient pool is a critical asset for conducting clinical research on a wide range of eye conditions, from common issues like glaucoma and cataracts to rare and complex genetic disorders.
The diversity within Moorfields’ patient population is particularly valuable for our clinical trials. In research, diversity ensures that the findings are robust, comprehensive, and applicable to the general population, rather than skewed toward a particular demographic. This inclusivity is essential for developing treatments that are effective across different population groups, leading to more equitable healthcare outcomes.
Beyond the diversity of conditions and demographics, Moorfields’ strong and established patient network significantly enhances the efficiency of patient recruitment—a process often cited as one of the most challenging aspects of clinical research in particularly with ocular studies. Recruiting sufficient numbers of participants who meet specific criteria is essential for ensuring that our studies produce meaningful data.
By leveraging Moorfields’ extensive reach, our team can more easily identify and enrol eligible participants, reducing the time and resources typically required for recruitment. The hospital’s reputation and trust within the community further bolster recruitment efforts, as patients are more likely to participate in studies conducted by an institution known for its excellence in eye care. This trust translates into higher participation rates and better retention, ensuring that our clinical trials proceed smoothly and efficiently.
Additionally, Moorfields’ specialised clinics and dedicated research units are adept at managing the recruitment and follow-up of trial participants. This targeted recruitment approach not only speeds up the enrolment process but also enhances the quality of the data collected, as participants are more likely to adhere to study protocols and remain engaged throughout the trial.
